These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22541575)

  • 1. Does aspirin really reduce the risk of colon cancer?
    Cleland JG
    Lancet; 2012 Apr; 379(9826):1586; author reply 1587. PubMed ID: 22541575
    [No Abstract]   [Full Text] [Related]  

  • 2. Does aspirin really reduce the risk of colon cancer?
    Jankowski J; Barr H; Moayyedi P
    Lancet; 2012 Apr; 379(9826):1586-7; author reply 1587. PubMed ID: 22541573
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin and colorectal cancer prevention in Lynch syndrome.
    Chan AT; Lippman SM
    Lancet; 2011 Dec; 378(9809):2051-2. PubMed ID: 22036018
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin may help colon cancer patients live longer.
    Harv Health Lett; 2013 Jan; 38(3):8. PubMed ID: 23556168
    [No Abstract]   [Full Text] [Related]  

  • 5. Daily aspirin reduces colorectal cancer incidence in patients with Lynch syndrome.
    Barton MK
    CA Cancer J Clin; 2012; 62(3):143-4. PubMed ID: 22411104
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
    Burn J; Gerdes AM; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen HF; Barker G; Crawford G; Elliott F; Movahedi M; Pylvanainen K; Wijnen JT; Fodde R; Lynch HT; Mathers JC; Bishop DT;
    Lancet; 2011 Dec; 378(9809):2081-7. PubMed ID: 22036019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention in Lynch syndrome.
    Burn J; Mathers JC; Bishop DT
    Fam Cancer; 2013 Dec; 12(4):707-18. PubMed ID: 23880960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine.
    Serrano D; Patrignani P; Stigliano V; Turchetti D; Sciallero S; Roviello F; D'Arpino A; Grattagliano I; Testa S; Oliani C; Bertario L; Bonanni B
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin and the prevention of colorectal cancer.
    Ferrández A; Piazuelo E; Castells A
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):185-95. PubMed ID: 22542156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of colorectal neoplasia.
    Wakeman C; Keenan J; Eteuati J; Hollington P; Eglinton T; Frizelle F
    ANZ J Surg; 2017 Dec; 87(12):E228-E232. PubMed ID: 26686322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome.
    Tuccori M; Filion KB; Azoulay L
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711870
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention.
    Hawk ET; Viner J; Richmond E; Umar A
    Cancer Chemother Biol Response Modif; 2003; 21():759-89. PubMed ID: 15338773
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response.
    Ait Ouakrim D; Dashti SG; Win AK
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711871
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.
    Ait Ouakrim D; Dashti SG; Chau R; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Leggett B; Macrae FA; Ahnen DJ; Casey G; Gallinger S; Haile RW; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26109217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-steroidal anti-inflammatory drugs and colorectal cancer prevention.
    Sangha S; Yao M; Wolfe MM
    Postgrad Med J; 2005 Apr; 81(954):223-7. PubMed ID: 15811884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention in hereditary colorectal cancer syndromes.
    Hawk E; Lubet R; Limburg P
    Cancer; 1999 Dec; 86(11 Suppl):2551-63. PubMed ID: 10630181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the potential chemopreventative effect of aspirin and rofecoxib on hereditary nonpolyposis colorectal cancer-like endometrial cancer cells in vitro through mechanisms involving apoptosis, the cell cycle, and mismatch repair gene expression.
    Wood NJ; Quinton NA; Burdall S; Sheridan E; Duffy SR
    Int J Gynecol Cancer; 2007; 17(2):447-54. PubMed ID: 17316360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aspirin in the primary prevention of colorectal cancer].
    Fernández Calderón M; Betés Ibáñez MT
    An Sist Sanit Navar; 2012; 35(2):261-7. PubMed ID: 22948427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis].
    Sheng JQ; Li SR; Yang XY; Zhang YH; Su H; Yu DL; Yan W; Geng HG
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):526-9. PubMed ID: 16681880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.